Caileigh Dougherty | Investor Relations |
Johnson Lau | Chief Executive Officer |
Daniel Lang | President, Athenex Cell Therapy |
Jeffrey Yordon | Chief Operating Officer |
Joe Annoni | Chief Financial Officer |
Kurt Gunter | Chief Medical Officer, Cell Therapy and Head of Regulatory Affairs |
Kevin DeGeeter | Oppenheimer & Co. |
Robyn Karnauskas | Truist Securities |
Jonathan Chang | SVB Leerink |
Yale Jen | Laidlaw & Company |
Good day, ladies and gentlemen, and welcome to the First Quarter 2022 Athenex Earnings Conference Call. After the presentation, there will be an opportunity to ask questions. [Operator Instructions] And as a reminder this conference is being recorded. I would now like to hand the conference over to Caileigh Dougherty, Director of Investor Relations.
You may begin.